Close
Nordic 9Nordic 9

Artis Ventures (investor - Venture Capital)

United States av.co
See something wrong or missing? Let us know
Offices:San Francisco

Artis Ventures (AV) is a financial services firm that finances early-to-late stage venture investments.

Average round investment:45.67M USD
Average number per year:1.0
Distribution: 2025 (1)2022 (1)2021 (1)
Portfolio companies: United Kingdom ValarianUnited Kingdom Replay BioUnited Kingdom ONI
Mostly invests in: United Kingdom United Kingdom (3) Security (1)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Artis Ventures

Name Criteria
Switzerland Julius Bär Group
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Tekla Capital Management
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United Kingdom Schroders
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Electronics, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Belgium Novalis Biotech
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Emerson Collective
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Arch Venture Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Electronics, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Cleveland Avenue
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
China GT Healthcare Capital
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Sanofi Ventures
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United Kingdom Syncona
81%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Top